Efficacy of Oral Ribavirin in Lung Transplant Patients With Respiratory Syncytial Virus Lower Respiratory Tract Infection

Journal of Heart and Lung Transplantation

Volumn 28, Issue 1, 2009, Pages 67-71

  Pelaez, Andres ^a   Lyon, G Marshall ^a   Force, Seth D ^a   Ramirez, Allan M ^a   Neujahr, David C ^a   Foster, Marianne ^a   Naik, Priyumvada M ^a   Gal, Anthony A ^a   Mitchell, Patrick O ^a   Lawrence, E Clinton ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE SODIUM SUCCINATE; RIBAVIRIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; NOSE SMEAR; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIVIRAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INFUSIONS, INTRAVENOUS; LUNG TRANSPLANTATION; MALE; METHYLPREDNISOLONE HEMISUCCINATE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RIBAVIRIN; SARCOIDOSIS; TIME FACTORS;

EID: 58149176081     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.10.008     Document Type: Article

References (12)

1. Ison M.G. Respiratory viral infections in transplant recipients. Antivir Ther 12 (2007) 627-638
2. Brief report. Respiratory syncytial virus activity-United States, July 2006-November 2007. MMWR Morbid Mortal Wkly Rep 56 (2007) 1263-1265
3. Kumar D., Erdman D., Keshavjee S., Peret T., et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 5 (2005) 2031-2036
4. McCurdy L.H., Milstone A., and Dummer S. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin. J Heart Lung Transplant 22 (2003) 745-753
5. Estenne M., Maurer J., Boehler A., et al. Bronchiolitis obliterans 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21 (2002) 297-310
6. Chakrabarti S., Collingham K.E., Holder K., et al. Pre-emptive oral ribavirin therapy of paramyxovirus is after haematopoietic stem cell transplantation: a pilot study. Bone Marrow Transplant 28 (2001) 759-763
7. Flynn J.D., Akers W.S., Jones M., et al. Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: case report and review of the literature. Pharmacotherapy 24 (2004) 932-938
8. Glanville A.R., Scott A.I., Morton J.M., et al. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant 24 (2005) 2114-2119
9. Ko J.P., Shepard J.A., Sproule M.W., et al. CT manifestations of respiratory syncytial virus infection in lung transplant recipients. J Comput Assist Tomogr 24 (2000) 235-241
10. Palmer Jr. S.M., Henshaw N.G., Howell D.N., et al. Community respiratory viral infection in adult lung transplant recipients. Chest 113 (1998) 944-950
11. Costa C., Libertucci D., Solidoro P., et al. Rapid shell vial culture for the detection of respiratory viruses from bronchoalveolar lavage in immunocompromised patients. Panminerva Med 49 (2007) 1-6
12. Sparrelid E., Ljungman P., Ekelof-Andstrom E., et al. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant 19 (1997) 905-908